🧠 The Signal Brief: AI Stock Insights & Picks
Two specialty insurers just crashed the top of our leaderboard. Skyward Specialty jumped 21 AI Score points in a month, the biggest riser in our top ten, and its neighbor Palomar isn't far behind. No Reddit hype, no AI narrative, just underwriting profits compounding quarter after quarter.
Meanwhile, PayPal mentions exploded 564% on takeover chatter, and Senator Tuberville filed sells on ten different stocks at once.
In today's Brief:
The Quiet Compounder: Skyward Specialty hits 81/100 after its fourth straight earnings beat and almost nobody's talking about it.
Tuberville's Everything Sale: Ten tickers, one filing. What's behind the portfolio-wide exit?
The PayPal Frenzy: Reddit mentions up 564% on Stripe/Advent buyout speculation.
Let's get started.
Sponsored by T3 Live T3Bible
5 traders. 137 years of combined experience. 1 guide.
|
One of the traders in this guide called the 2008 crash live from the NYSE floor on CNBC. It's still on YouTube. 
Another manages a 7-figure personal book every day and says most traders would make more money doing less. A third uses a framework from the 1930s that most modern traders have never heard of. It still works. The other two? A former accountant who trades nothing but gaps. And an options income trader who sold his trading company — twice. T3 Live asked all five the same question: "If a trader could only read one chapter of advice from you — what would you write?" The result is The Trader's Bible. 7 chapters. Small account growth, options, gap trading, earnings, Wyckoff price action, income strategies. Written from the content of the traders themselves. Get your copy of The Trader's Bible here T3 Live P.S. — Sami's 5-point gap scoring system alone is worth your time. I've never seen anyone else teach it this way. |
📈 Top AI Scorer of the Week
Skyward Specialty's AI score just jumped 21 points to 81, the biggest move anywhere in our top ten. The stock spent a year going nowhere and barely made a headline doing it. Four straight earnings beats say the quiet part: the business broke out long before the price did.
Stock spotlight: Skyward Specialty Insurance (SKWD)
Skyward Specialty is a Houston-based specialty P&C insurer that deliberately avoids crowded commercial lines and instead dominates niches: surety, medical stop-loss, professional lines, transactional E&S, where underwriting expertise beats scale. Its "Rule Your Niche" playbook has produced one of the most consistent earnings machines in small-cap insurance. And unlike almost everything else in our top ten, it has zero AI-narrative premium baked in: the P/E is 14.
The data:
Earnings: Q1 2026 net income of $49.7M on $395.7M in revenue. Revenue up ~20% year over year. EPS of $1.25 beat the $0.97 estimate, the fourth straight beat and the biggest yet.
Price momentum: $59.56, up about 20% in the past month after a flat year. RSI at 55, so not technically overbought even after the run.
Market cap: $2.4B. P/E of 14.3.
Analyst ratings: 6 buys, 0 holds, 0 sells on the tracked panel. Piper Sandler and KBW both raised targets to $72 in the past two weeks.
Alternative data from the past few months:
Job postings: ↑ 12.5% month over month as hiring re-accelerates off spring lows
Headcount: ↑ ~5% since February to 609 LinkedIn employees
Employee rating: 90/100, with our employment sub-score at 88. Insurers don't retain underwriting talent like that unless the book is working
Reddit mentions: Effectively zero. This is the anti-meme stock. The signal here is purely operational.
The verdict:
AI score: 81/100 — buy signal.
Current price: $59.56
Price prediction: $70.77 (+21.3% upside)
Analyst price target: $72 (+20.9% upside)
Bottom line: The stock went nowhere for a year while EPS beats got bigger every quarter. Then the market noticed all at once. Our model's 21-point re-rate reflects hiring turning back up, elite employee sentiment, and a fourth straight blowout quarter, all at 14x earnings.
The caveats: Web traffic is soft (largely irrelevant for a specialty insurer), insider activity is mixed (a director bought ~2,000 shares at $47 in May; an officer sold ~8,400 at $51 in June), and after a 20% monthly run, some consolidation would be normal. But the signal is clear: the fundamentals broke out before the stock did, and the stock is just now catching up.
Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.
🔎 Alt-Data Signals
What’s cooking in markets right now?
Congress Trades
Tommy Tuberville filed the week's most dramatic batch: sells across ten names, all traded June 8-9 and disclosed July 16.
Out: Lockheed Martin, Mastercard, and Procter & Gamble ($15K-$50K each), plus Pfizer, Duke Energy, CSX, Wabtec, Accenture, Tractor Supply, and American Water Works in smaller lots. Not so much a rebalance as a liquidation: a portfolio-wide exit from blue chips spanning defense, payments, staples, rails, and utilities.
Also worth noting: these trades sat undisclosed for over five weeks, right up against the STOCK Act's 45-day window. By the time you can see a trade like this, the trade is old news.
Bought $LHX and $ICE, sold $UNH ($1K-$15K each), Rep. Rich McCormick, traded June 12, disclosed July 10. McCormick sits on House Armed Services, which marked up the FY2027 defense budget this spring, so the L3Harris buy files neatly under committee overlap. So far the trade hasn't worked: LHX is down 7.6% since, while the UnitedHealth he sold is up 7.3%.
Bought $UNH and $CEG ($1K-$15K each), Sen. John Boozman, traded June 4 and 12, disclosed July 13. The UnitedHealth buy is up 10.5% already, catching the most violent recovery story of the summer mid-run. Constellation, the top stock on our AI leaderboard at 83, is roughly flat since.
Bought $ETN ($1K-$15K), Rep. Ro Khanna, traded June 5, disclosed July 10. Last week it was fifty buys across AI silicon. This week the household added Eaton, the company selling the electrical hardware that powers AI data centers. Flat since the trade, but the theme continues, and so does the irony from Congress's loudest voice for banning these trades.
Bought $ZTS ($15K-$50K), sold $TSCO ($1K-$15K), Rep. Chuck Fleischmann, traded June 9, disclosed July 13. Out of farm retail, into pet pharma, and the buy was the bigger ticket.
Reddit Alerts
(You can get all of these alerts as notifications on your phone with the AltIndex App)
PayPal ($PYPL): Mentions exploded +564%, the biggest spike on the platform, on reports of a Stripe/Advent takeover approach. The threads are split between merger-arb math (will the board reject a lowball first offer?) and FTC skepticism.
UnitedHealth ($UNH): Mentions up +220%, and our real-time tracker flagged sustained discussion of the stock's run from ~$250 to ~$450 in three months plus a well-received earnings call.
AST SpaceMobile ($ASTS): Mentions up +366%, but this one's pain, not euphoria. The satellite name was Reddit's consensus 2026 pick, and the threads are full of drawdown talk.
Alternative Data Points of Interest from the Past 3 Months:
Dick's Sporting Goods ($DKS): Job postings nearly doubled this week, +93% to ~6,350 a week.
Intuit ($INTU): Job postings up +68% to ~1,540 a week.
Nvidia ($NVDA): Even the biggest company on earth is still scaling. Postings up +32% to ~1,940 a week.
Mastercard ($MA): Social sentiment jumped +32% to 85/100, one of the sharpest sentiment shifts we tracked this week.
Uber ($UBER): Postings up +28% to ~8,140 a week and Reddit mentions up +192%.
📉 Lowest Scores: Stocks Losing Signal
These are the five worst-rated stocks on our platform. Our AI model sees these as strong sell signals. Always do your own research.
🐦 Meme of the Week
👋 See You Next Week
That’s it for today. Hope you found these signals helpful and/or interesting.
Have a great weekend, and happy trading.
— Brandon and Blake
The information provided in AltIndex (LLC) is for informational and educational purposes only and should not be construed as financial advice, investment advice, or a recommendation to buy or sell any securities. AltIndex (LLC) is not a registered investment advisor, broker-dealer, or licensed financial planner. Always do your own research and consult with a licensed financial advisor before making any investment decisions. We may hold positions in or receive compensation from the companies or products mentioned. Disclosures will be made where applicable.
Invested Early, Stocks & Income, AltIndex (LLC), Finance Wrapped, The Chain, and Future Funders are all owned by Invested, Inc.
Not financial advice or a recommendation to buy or sell any security. Small and micro-cap stocks are volatile and carry a real risk of loss. All figures sourced from AltIndex as of June 26, 2026. Always do your own research. Invested Early is published by Invested Inc.